Welcome to GeniPhys
|
GeniPhys is developing and commercializing its patented Collymer™ technology -a first-in-class polymerizable (scaffold-forming) collagen that supports custom design and fabrication of collagen materials for accelerated and improved tissue restoration and regeneration.
Pre-clinical studies demonstrate that Collymer materials exhibit an uncommon mode of action, providing a long-lasting and physically-stable scaffold that supports site-appropriate tissue integration and new tissue formation, avoiding inflammation, fibrosis, and scarring. Potential material applications extend from regenerative tissue replacements (including soft tissue, cardiovascular, musculoskeletal, and orthopedic) to delivery of pharmaceutical and cell-based therapies and to sensor/device coatings. |
|
What differentiates Collymer materials from other options currently on the market is their broad customization and paradigm-shifting tissue response, where they provide a long-lasting, mechanically-stable natural scaffold that supports new tissue formation in absence of an inflammatory-mediated foreign body response. |
Our Mission. |
Our Vision. |
|
Revolutionize regenerative medicine by applying Collymer in ways that significantly improve patient lives and medical care standards globally across multiple clinical applications.
|
Become the leading developer and manufacturer of innovative regenerative biomaterials to advance the global standard of care in diverse and evolving areas of healthcare.
|
Collymer SAS has only been cleared for specific uses by the FDA and is not yet commercially available.